4.6 Letter

Sustained sutimlimab response for 3 years in patients with cold agglutinin disease: A phase I, open-label, extension trial

Journal

BRITISH JOURNAL OF HAEMATOLOGY
Volume 198, Issue 4, Pages E59-E62

Publisher

WILEY
DOI: 10.1111/bjh.18289

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available